Literature DB >> 21126606

Thrombocytopenia after vaccination: case reports to the US Vaccine Adverse Event Reporting System, 1990-2008.

Emily Jane Woo1, Robert P Wise, David Menschik, Sean V Shadomy, John Iskander, Judy Beeler, Frederick Varricchio, Robert Ball.   

Abstract

We reviewed thrombocytopenia (TP) reports to the US Vaccine Adverse Event Reporting System (VAERS). We examined TP patterns for differences in single versus multiple immunization reports, presence of a live viral vaccine, seriousness, age, and interval to symptom onset. We found 1510 reports of possible TP and after exclusions evaluated 1440 for possible causes. Most (1078; 75%) met the regulatory definition of a serious adverse event. TP was reported after inactivated and live viral vaccines. Platelet counts <10×10(9)/L were reported. Identified vaccines could be prioritized for hypothesis-testing studies. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21126606     DOI: 10.1016/j.vaccine.2010.11.051

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Vaccine administration and the development of immune thrombocytopenic purpura in children.

Authors:  Valerio Cecinati; Nicola Principi; Letizia Brescia; Paola Giordano; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

2.  COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone: A case report.

Authors:  Md Asaduzzaman; Bidrum Purkayastha; M M Jahangir Alam; Shishir Ranjan Chakraborty; Soumitra Roy; Nasad Ahmed
Journal:  J Neuroimmunol       Date:  2022-05-08       Impact factor: 3.221

3.  Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.

Authors:  David Martin; David Menschik; Marthe Bryant-Genevier; Robert Ball
Journal:  Drug Saf       Date:  2013-07       Impact factor: 5.228

Review 4.  Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review.

Authors:  Rana I Oueijan; Olivia R Hill; Peter D Ahiawodzi; Pius S Fasinu; Dorothea K Thompson
Journal:  Medicines (Basel)       Date:  2022-08-11

Review 5.  Frequently asked questions on seven rare adverse events following immunization.

Authors:  G L D'alò; E Zorzoli; A Capanna; G Gervasi; E Terracciano; L Zaratti; E Franco
Journal:  J Prev Med Hyg       Date:  2017-03

6.  Immune thrombocytopenic purpura risk by live, inactivated and simultaneous vaccinations among Japanese adults, children and infants: a matched case-control study.

Authors:  Hiroshi Yokomichi; Keiko Tanaka-Taya; Rie Koshida; Takashi Nakano; Yoshinori Yasui; Masaaki Mori; Yuka Ando; Saeko Morino; Hideo Okuno; Hiroshi Satoh; Satoru Arai; Mie Mochizuki; Zentaro Yamagata
Journal:  Int J Hematol       Date:  2020-04-06       Impact factor: 2.319

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.